Evidence map›Paper›PMID 30009530›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2019

Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome.

Min Sun Shin, Youna Kang, Elizabeth R Wahl, Hong-Jai Park, Rossitza Lazova, Lin Leng, Mark Mamula, Smita Krishnaswamy, Richard Bucala, Insoo Kang

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Overlapping Clinical Presentation of Long COVID and Postacute COVID-19 Vaccination Syndrome: Phenotypes, Severity, and Biomarkers.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. PD-1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Dualistic roles and mechanistic insights of macrophage migration inhibitory factor in brain injury and neurodegenerative diseases.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Min Sun ShinYale University School of Medicine, New Haven, Connecticut.
Youna KangYale University School of Medicine, New Haven, Connecticut.
Elizabeth R WahlYale University School of Medicine, New Haven, Connecticut, and University of Washington, Seattle.
Hong-Jai ParkYale University School of Medicine, New Haven, Connecticut.
Rossitza LazovaYale University School of Medicine, New Haven, Connecticut, and California Skin Institute, San Jose.
Lin LengYale University School of Medicine, New Haven, Connecticut.
Mark MamulaYale University School of Medicine, New Haven, Connecticut.
Smita KrishnaswamyYale University School of Medicine, New Haven, Connecticut.
Richard BucalaYale University School of Medicine, New Haven, Connecticut.
Insoo KangYale University School of Medicine, New Haven, Connecticut.
Yale University · US

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Mechanisms of Rheumatoid Synovial Fibroblast ActivationR01AR049610 · NIAMS · YALE UNIVERSITY · PI BUCALA, RICHARD J · 2002 to 2018
$5.0M
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine ResponseR01AG055362 · NIA · YALE UNIVERSITY · PI KANG, INSOO, SHAW, ALBERT C · 2017 to 2021
$4.0M
Studying lupus Th17 cell characteristics and their modulations by IL-27R21AI126604 · NIAID · YALE UNIVERSITY · PI KANG, INSOO · 2016 to 2017
$461k
Aging and IL-7-Mediated CD8+ T Cell SurvivalR56AG028069 · NIA · YALE UNIVERSITY · PI KANG, INSOO · 2015 to 2015
$416k
NCATS NIH HHS UL1 TR000142NIAID NIH HHS R21 AI126604NIAMS NIH HHS R01 AR049610NIA NIH HHS R01 AG055362NIA NIH HHS R56 AG028069NIH HHS R56AG0280691
6 · The paper itself

Abstract

objectiveHigh-expression alleles of macrophage migration inhibitory factor (MIF) are linked genetically to the severity of systemic lupus erythematosus (SLE). The U1 small nuclear RNP (snRNP) immune complex containing U1 snRNP and anti-U1 snRNP antibodies, which are found in patients with SLE, activates the NLRP3 inflammasome, comprising NLRP3, ASC, and procaspase 1, in human monocytes, leading to the production of interleukin-1β (IL-1β). This study was undertaken to investigate the role of the snRNP immune complex in up-regulating the expression of MIF and its interface with the NLRP3 inflammasome.

methodsMIF, IL-1β, NLRP3, caspase 1, ASC, and MIF receptors were analyzed by enzyme-linked immunosorbent assay, Western blotting, quantitative polymerase chain reaction, and cytometry by time-of-flight mass spectrometry (CytoF) in human monocytes incubated with or without the snRNP immune complex. MIF pathway responses were probed with the novel small molecule antagonist MIF098.

resultsThe snRNP immune complex induced the production of MIF and IL-1β from human monocytes. High-dimensional, single-cell CytoF analysis established that MIF regulates activation of the NLRP3 inflammasome, including findings of a quantitative relationship between MIF and its receptors and IL-1β levels in the monocytes. MIF098, which blocks MIF binding to its cognate receptor, suppressed the production of IL-1β, the up-regulation of NLRP3, which is a rate-limiting step in NLRP3 inflammasome activation, and the activation of caspase 1 in snRNP immune complex-stimulated human monocytes.

conclusionThe U1 snRNP immune complex is a specific stimulus of MIF production in human monocytes, with MIF having an upstream role in defining the inflammatory characteristics of activated monocytes by regulating NLRP3 inflammasome activation and downstream IL-1β production. These findings provide mechanistic insight and a therapeutic rationale for targeting MIF in subgroups of lupus patients, such as those classified as high genotypic MIF expressers or those with anti-snRNP antibodies.

Indexed as

Antigen-Antibody ComplexAutoantibodiesBlotting, WesternCARD Signaling Adaptor ProteinsEnzyme-Linked Immunosorbent AssayFlow CytometryHumansInflammasomesInterleukin-1betaIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMass SpectrometryMonocytesNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, ImmunologicRibonucleoprotein, U1 Small NuclearAntigen-Antibody ComplexAutoantibodiesCARD Signaling Adaptor ProteinsIL1B protein, humanInflammasomesInterleukin-1betaIntramolecular Oxidoreductasesmacrophage migration inhibitory factor receptorMacrophage Migration-Inhibitory FactorsMIF protein, humanNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanPYCARD protein, humanReceptors, ImmunologicRibonucleoprotein, U1 Small Nuclear

Identifiers

PMID30009530
PMCPMC6310104
OpenAlexW2883094607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.